[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
Teramoto
S
S
Kita
E
E
Mikasa
K
K
Hamada
K
K
Konishi
M
M
Maeda
K
K
Sakamoto
M
M
Tsujimoto
M
M
Mori
K
K
Sawaki
M
M
Narita
N
N
D000230:Adenocarcinoma / Q000276:immunology; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018287:Carcinoma, Large Cell / Q000276:immunology; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D017291:Clarithromycin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D018664:Interleukin-12 / Q000032:analysis / Q000235:genetics*; D008175:Lung Neoplasms / Q000276:immunology*; D008297:Male; D012333:RNA, Messenger / Q000032:analysis*
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D012333:RNA, Messenger; D018664:Interleukin-12; D017291:Clarithromycin